These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 215846

  • 1. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Kessinger A, Lemon HM, Foley JF.
    J Surg Oncol; 1978; 10(6):543-7. PubMed ID: 215846
    [Abstract] [Full Text] [Related]

  • 2. Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.
    Sweet DL, Hendler FJ, Hanlon K, Hekmatpanah J, Griem ML, Duda EE, Mulligan B, Wollman RL.
    Cancer Treat Rep; 1979; 63(11-12):1707-11. PubMed ID: 230893
    [Abstract] [Full Text] [Related]

  • 3. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 4. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
    Bashir R, Hochberg FH, Linggood RM, Hottleman K.
    J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.
    Elliott TE, Dinapoli RP, O'Fallon JR, Krook JE, Earle JD, Morton RF, Levitt R, Tschetter LK, Scheithauer BW, Pfeifle DM, Twito DI, Nelimark RA.
    J Neurooncol; 1997 Jul; 33(3):239-50. PubMed ID: 9195495
    [Abstract] [Full Text] [Related]

  • 6. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F, Prados M, Russell C, Weissman D, Evans R, Cook P, Burton G, Eisenberg PD, Valenzuela R, Verkh L.
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [Abstract] [Full Text] [Related]

  • 7. Long-term survivors of high-grade malignant astrocytomas.
    Dara P, Slater LM, Talreja D, Armentrout SA.
    Med Pediatr Oncol; 1980 Mar; 8(2):187-91. PubMed ID: 6252428
    [Abstract] [Full Text] [Related]

  • 8. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzig GP.
    J Clin Oncol; 1986 May; 4(5):639-45. PubMed ID: 3009725
    [Abstract] [Full Text] [Related]

  • 9. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 10. Treatment of malignant gliomas in adults with BCNU plus metronidazole.
    Stewart DJ, Benoit B, Richard MT, Hugenholtz H, Dennery J, Russell N, Peterson E, Grahovac Z, Belanger G, Maroun JA.
    J Neurooncol; 1984 Jan; 2(1):53-8. PubMed ID: 6088725
    [Abstract] [Full Text] [Related]

  • 11. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A, Bock HC, Brück W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A.
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [Abstract] [Full Text] [Related]

  • 12. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS.
    Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):969-75. PubMed ID: 9869217
    [Abstract] [Full Text] [Related]

  • 13. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):535-43. PubMed ID: 10348282
    [Abstract] [Full Text] [Related]

  • 14. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW, Parkinson D, Wolpert SM, Kasdon DL, Kwan ES, Laucella M, Anderson ML.
    Neurosurgery; 1987 Apr 01; 20(4):577-83. PubMed ID: 3587550
    [Abstract] [Full Text] [Related]

  • 15. Pathology of high-dose intraarterial BCNU.
    Kleinschmidt-DeMasters BK, Geier JM.
    Surg Neurol; 1989 Jun 01; 31(6):435-43. PubMed ID: 2541513
    [Abstract] [Full Text] [Related]

  • 16. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS, Ensminger WD, Chandler WF, Layton PB, Junck L, Knake J, Vine AK.
    J Neurosurg; 1984 Sep 01; 61(3):423-9. PubMed ID: 6747681
    [Abstract] [Full Text] [Related]

  • 17. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 18. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
    Levin VA, Hoffman WF, Pischer TL, Seager ML, Boldrey EB, Wilson CB.
    Cancer Treat Rep; 1978 Dec 15; 62(12):2071-6. PubMed ID: 221113
    [Abstract] [Full Text] [Related]

  • 19. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP.
    J Clin Oncol; 1987 May 15; 5(5):783-9. PubMed ID: 3553437
    [Abstract] [Full Text] [Related]

  • 20. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR, North Central Cancer Treatment Group 93-72-52, Southwest Oncology Group 9503 Trials.
    J Clin Oncol; 2006 Aug 20; 24(24):3871-9. PubMed ID: 16921039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.